CHM chimeric therapeutics limited

Ann: 2024 Annual Report update, page-5

  1. 3,100 Posts.
    lightbulb Created with Sketch. 1173
    Disappointed but the Annual Report is completely separate from a CR unless the board is concerned about continuing to operate while insolvent which would have of course been commented upon in the Annual Report's audit opinion and in the notes to the accounts etc. Without the CR perhaps the auditors would have provided a qualified audit opinion or reported an inability to opine on CHM's financial statements. Somewhat of a disaster and reflects poorly on the board and management but primarily Hopper.

    Perhaps a white knight (IMU) will be the outcome but if so do hope it is independent from Hopper's sphere of influence.



 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $432 98K

Buyers (Bids)

No. Vol. Price($)
26 22188206 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 25892021 31
View Market Depth
Last trade - 13.15pm 16/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.